1. Financial Performance Metrics
- Revenue: $2.764 billion, down 0.25% year-over-year but strong against pre-pandemic benchmarks.
- Net Income: $259 million with a net income margin of 9.37%.
- Adjusted EBITDA: $311 million, with adjusted EBITDA margin over 11%.
- EPS: $7.19 (diluted), reflecting a 30.33% decrease year-over-year, indicating challenges in profitability amidst economic pressures.
2. Balance Sheet Health
- Total Assets: $33.419 billion; Total Liabilities: $33.762 billion, resulting in negative equity of $349 million, highlighting leverage levels and debt management strategies.
- Cash: $559 million alongside liquidity of approximately $800 million; the leverage ratio stands at 1.7x, maintaining compliance with financial covenants.
- Cash Flow: Net cash from operating activities was $793 million, demonstrating positive operational cash generation despite significant capital expenditures of $2.669 billion in 2023.
3. Efficiency Ratios and Margins
- Gross Profit Margin: 28%; the operating income margin is at 15.38%, reflective of effective cost discipline, despite the inflationary environment.